PE LIFELAB STUDIOS RFP 250031 AMD 3.PDF
Extracted text (via pymupdf_layout)
7513 characters
C-86-25-049-X-00 / PH RFP 250031 AMENDMENT 3 AMENDMENT TO CONTRACT PH RFP 250031 BETWEEN MARICOPA COUNTY BY AND THROUGH ITS DEPARTMENT OF PUBLIC HEALTH AND LIFELAB STUDIOS INC. I. The purpose of this amendment is to add additional funding from the Overdose Data to Action (OD2A) grant received by the Centers for Disease Control and Prevention (CDC) and administered by the Maricopa County Department of Public Health. The contract is currently funded with Opioid Settlement Funds (OSF), also administered by the Maricopa County Department of Public Health. II. The above-named contract is hereby amended as specified below: A. Exhibit B-2 -YEAR 2 BUDGET SHEET & BUDGET NARRATIVE, shall be revised to include Exhibit B-2 Addendum - Year 2 Overdose Data to Action (OD2A) Budget Sheet & Narrative (November 18, 2026 to March 31, 2027), which appears beginning on page 3 of this amendment. This additional amount constitutes the Overdose Data to Action (OD2A) portion that is being added for Year 2. B. Exhibit A – PRICING AND RESPONDENT INFORMATION shall be updated to add an additional $130,000 of Overdose Data to Action (OD2A) Funding for the Year 2 budget period to begin November 18, 2026 to March 31, 2027, making the total not-to-exceed amount $530,409. C. SECTION 4.0 AVAILABILITY OF FUNDS shall be updated with the following language: “4.3 All Overdose Data to Action (OD2A) Funds identified in Exhibit B-2, Year 2 Budget Sheet and Narrative, shall be expended within the budget period specified therein. Federal funds identified in the budget may be carried forward at the discretion of the Maricopa County Department of Public Health to the extent permitted by the funding agency.” D. Exhibit D-2, SCOPE OF WORK shall be replaced with Exhibit D-3, Revised Year 2 Scope of Work (November 18, 2026 – March 31, 2027), which begins on page 6 of this document. This updated scope of work includes deliverables from both funding sources. E. Exhibit L, Unallowable Activities and Expenditures, has been newly added and begins on page 11. It pertains to the newly added Overdose Data to Action (OD2A) funding. F. Exhibit M, Notice of Award, has been newly added and begins on page 13. This is the award information that pertains to the newly added Overdose Data to Action (OD2A) funding. Page 1 of 14 C-86-25-049-X-00 / PH RFP 250031 AMENDMENT 3 III. All other terms and conditions of the contract shall remain in full force and effect. IN WITNESS WHEREOF, the parties agree to the changes indicated herein: FOR AND ON BEHALF OF FOR AND ON BEHALF OF MARICOPA COUNTY LIFELAB STUDIOS, INC. By: By: Chair, Board of Supervisors Lifelab Studios, Inc. 10/15/2026 Date Date ATTEST Clerk of the Board Date APPROVED AS TO FORM Attorney for Maricopa County Date Page 2 of 14 C-86-25-049-X-00 / PH RFP 250031 AMENDMENT 3 Exhibit B-2 Addendum Year 2 OD2A Budget Sheet & Narrative November 18, 2026 – March 31, 2027 Page 3 of 14 C-86-25-049-X-00 / PH RFP 250031 AMENDMENT 3 Page 4 of 14 C-86-25-049-X-00 / PH RFP 250031 AMENDMENT 3 Page 5 of 14 C-86-25-049-X-00 / PH RFP 250031 AMENDMENT 3 Exhibit D-3, Revised Year 2 Scope of Work (November 18, 2026 – March 31, 2027) Page 6 of 14 C-86-25-049-X-00 / PH RFP 250031 AMENDMENT 3 Page 7 of 14 C-86-25-049-X-00 / PH RFP 250031 AMENDMENT 3 Page 8 of 14 C-86-25-049-X-00 / PH RFP 250031 AMENDMENT 3 Page 9 of 14 C-86-25-049-X-00 / PH RFP 250031 AMENDMENT 3 Page 10 of 14 C-86-25-049-X-00 / PH RFP 250031 AMENDMENT 3 Exhibit L UNALLOWABLE ACTIVITIES AND EXPENDITURES This document is to give an overview of general unallowable activities and expenditures related to overdose prevention under OD2A: LOCAL. While some of the activities listed below may contribute to overdose prevention in some manner, they are either not allowed by HHS, CDC, or congressional appropriations language. This is not an exhaustive list. Activities related to harm reduction: • Establish a new Syringe Services Program (SSPs) • Infrastructure costs for SSPs except when contributing to co-location of treatment (funds may be used for additional expenses associated with co-location) • Provision of equipment solely intended for illegal drug use, such as syringes, cookers/spoons, syringes, and pipes • Procurement of other equipment solely intended for preparing drugs for illegal drug injection, such as sterile water, filters, tourniquets, razors, straws, plastic cards, and tiny spoons • Safe injection sites (controlled environments that facilitate safer use of illicit drugs by providing medical staff, clean facilities, and education) and developing educational outreach and guidance or materials (including mass media, print, digital, or other) about supervised injection facilities • Purchasing and distributing fentanyl test strips for testing in biological samples for clinical decision-making purposes • Purchasing basic food, health, or personal items if not intended to support outreach or engage individuals in venue-based programs (e.g., meal or grocery cards, first aid kits, hygiene items, clothes, etc.) • Pharmacy voucher program that provides participants with vouchers redeemable for free syringes at participating pharmacies Activities related to public health/public safety: • Drug disposal, including the implementation or expansion of drug disposal programs, drug take back programs, drug drop boxes, and drug disposal bags • Purchase of handheld drug testing machines such as TruNarc, Fourier-transform infrared (FTIR) machines, or HPMS machines for the purposes of reducing possible law enforcement exposure to fentanyl • Public safety activities that do not include overlap/collaboration with public health partners and objectives Page 11 of 14 C-86-25-049-X-00 / PH RFP 250031 AMENDMENT 3 Activities related to health systems: • Purchasing, leasing, or renting equipment intended to help EMS and other clinicians treat and manage overdose • Provision of SUD treatment that includes MOUD and the purchase of medications such as Methadone, Buprenorphine, and Naltrexone • Directly funding or expanding the provision of substance use treatment • Paying for fees associated with clinicians obtaining waived status for DATA waivers. This applies to direct reimbursements, contracts and waiver fees • Financial incentives to encourage clinicians to participate in educational sessions and training activities (e.g., participation in academic detailing, attending seminars, completion of post-session surveys) • Paying for the following services (only referral or linkage to them is allowed): o Treatment for substance use disorder (MOUD) o Behavioral therapy (e.g., cognitive behavioral therapy) o Housing assistance o Food assistance o Medical care • Specialized clinical care, if indicated, such as pain management Other generalized, unallowable activities: • Funding or subsidizing costs associated with programs other than those specifically targeting overdose prevention • Childcare and childcare-related purchases (e.g. pack-n-play) • Furniture or equipment (purchase or leasing vehicles may be allowable expenses for linkage to care activities) • Research • Prevention of Adverse Childhood Experiences (ACEs) as a standalone activity Funding cannot be used to directly fund or expand the direct provision of substance use disorder treatment programs. Such activities are outside the scope of this grant. Page 12 of 14 C-86-25-049-X-00 / PH RFP 250031 AMENDMENT 3 Exhibit M Notice of Award Page 13 of 14 C-86-25-049-X-00 / PH RFP 250031 AMENDMENT 3 Page 14 of 14